Sandy Spring Bank’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $11.9K | Hold |
2,600
| – | – | ﹤0.01% | 816 |
|
|
2024
Q4 | $14.7K | Sell |
2,600
-800
| -24% | -$4.51K | ﹤0.01% | 804 |
|
|
2024
Q3 | $16.5K | Buy |
3,400
+800
| +31% | +$3.87K | ﹤0.01% | 776 |
|
|
2024
Q2 | $12.7K | Hold |
2,600
| – | – | ﹤0.01% | 842 |
|
|
2024
Q1 | $34.5K | Buy |
2,600
+400
| +18% | +$5.31K | ﹤0.01% | 655 |
|
|
2023
Q4 | $30.7K | Hold |
2,200
| – | – | ﹤0.01% | 644 |
|
|
2023
Q3 | $29.2K | Hold |
2,200
| – | – | ﹤0.01% | 646 |
|
|
2023
Q2 | $41.3K | Hold |
2,200
| – | – | ﹤0.01% | 581 |
|
|
2023
Q1 | $31.7K | Hold |
2,200
| – | – | ﹤0.01% | 615 |
|
|
2022
Q4 | $42.6K | Hold |
2,200
| – | – | ﹤0.01% | 560 |
|
|
2022
Q3 | $76K | Hold |
2,200
| – | – | ﹤0.01% | 446 |
|
|
2022
Q2 | $34K | Hold |
2,200
| – | – | ﹤0.01% | 590 |
|
|
2022
Q1 | $50K | Hold |
2,200
| – | – | ﹤0.01% | 543 |
|
|
2021
Q4 | $81K | Buy |
2,200
+600
| +38% | +$22.1K | ﹤0.01% | 483 |
|
|
2021
Q3 | $75K | Hold |
1,600
| – | – | ﹤0.01% | 476 |
|
|
2021
Q2 | $96K | Buy |
+1,600
| New | +$96K | 0.01% | 439 |
|